C. Escrieut

发表

A Novel Mechanism for JAK2 Activation by a G Protein-coupled Receptor, the CCK2R

A. Kowalski-Chauvel, L. Pradayrol, C. Seva, 2005, Journal of Biological Chemistry.

Evidence for a Direct Interaction between the Penultimate Aspartic Acid of Cholecystokinin and Histidine 207, Located in the Second Extracellular Loop of the Cholecystokinin B Receptor*

B. Maigret, N. Vaysse, S. Silvente-Poirot, 1999, The Journal of Biological Chemistry.

Identification of Two Amino Acids of the Human Cholecystokinin-A Receptor That Interact with the N-terminal Moiety of Cholecystokinin*

B. Maigret, N. Vaysse, L. Moroder, 1997, The Journal of Biological Chemistry.

Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumors

J. Reubi, B. Waser, C. Escrieut, 2012, Molecular and Cellular Endocrinology.

Structure of cholecystokinin receptor binding sites and mechanism of activation/inactivation by agonists/antagonists.

B. Maigret, L. Pradayrol, S. Silvente-Poirot, 2002, Pharmacology & toxicology.

The Biologically Crucial C Terminus of Cholecystokinin and the Non-peptide Agonist SR-146,131 Share a Common Binding Site in the Human CCK1 Receptor

B. Maigret, L. Pradayrol, S. Silvente-Poirot, 2002, The Journal of Biological Chemistry.

Arginine 197 of the cholecystokinin‐A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin

B. Maigret, N. Vaysse, S. Silvente-Poirot, 2008, Protein science : a publication of the Protein Society.

Arginine 336 and Asparagine 333 of the Human Cholecystokinin-A Receptor Binding Site Interact with the Penultimate Aspartic Acid and the C-terminal Amide of Cholecystokinin*

B. Maigret, N. Vaysse, Jean Martinez, 1999, The Journal of Biological Chemistry.

Essential Interaction of Egr-1 at an Islet-specific Response Element for Basal and Gastrin-dependent Glucagon Gene Transactivation in Pancreatic α-Cells*

S. Marchal-Victorion, L. Pradayrol, C. Seva, 2005, Journal of Biological Chemistry.

c-Jun NH(2)-terminal kinase pathway in growth-promoting effect of the G protein-coupled receptor cholecystokinin B receptor: a protein kinase C/Src-dependent-mechanism.

L. Daulhac, A. Kowalski-Chauvel, L. Pradayrol, 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Identification of a region of the N-terminal of the human CCKA receptor essential for the high affinity interaction with agonist CCK.

N. Vaysse, C. Escrieut, D. Fourmy, 1995, Biochemical and biophysical research communications.

Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas.

N. Tarasova, R. Gomis, N. Vaysse, 1999, Diabetes.

Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors?

Bernard Maigret, B. Maigret, L. Pradayrol, 2003, Trends in pharmacological sciences.

Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.

N. Vaysse, C. Escrieut, D. Fourmy, 1994, Molecular pharmacology.

Transgenic CCK-B/gastrin receptor mediates murine exocrine pancreatic secretion.

N. Vaysse, C. Escrieut, D. Fourmy, 1998, Gastroenterology.

The third intracellular loop of the rat and mouse cholecystokinin-A receptors is responsible for different patterns of gene activation.

S. Silvente-Poirot, C. Escrieut, D. Fourmy, 2000, Molecular pharmacology.

Combination of molecular modeling, site-directed mutagenesis, and SAR studies to delineate the binding site of pyridopyrimidine antagonists on the human CCK1 receptor.

M. Martín-Martínez, B. Maigret, M. García-López, 2005, Journal of medicinal chemistry.

Cholecystokinin 1 receptor modulates the MEKK1‐induced c‐Jun trans‐activation: structural requirements of the receptor

Jean Martinez, C. Escrieut, D. Fourmy, 2006, British journal of pharmacology.

Cyclodextrin as Carrier of Peptide Hormones. Conformational and Biological Properties of β-Cyclodextrin/Gastrin Constructs

G. Müller, L. Moroder, C. Escrieut, 1998 .

Peptide/benzodiazepine hybrids as ligands of CCK(A) and CCK(B) receptors.

G. Klebe, A. Schafferhans, G. Müller, 2000, Biopolymers.

Distinct CCK-2 receptor conformations associated with β-arrestin-2 recruitment or phospholipase-C activation revealed by a biased antagonist.

I. Tikhonova, C. Escrieut, D. Fourmy, 2013, Journal of the American Chemical Society.

New anthranilic acid based antagonists with high affinity and selectivity for the human cholecystokinin receptor 1 (hCCK1-R).

F. Gasparrini, A. Ciogli, E. Marco, 2011, Journal of medicinal chemistry.

Determination of trace amounts of nickel by atomic-absorption spectrometry after carbonyl generation.

J. Vandaele, C. Escrieut, J. Alary, 1986, Talanta.

Mechanism for Src activation by the CCK2 receptor: Patho-physiological functions of this receptor in pancreas.

A. Kowalski-Chauvel, C. Seva, A. Ferrand, 2006, World journal of gastroenterology.

Metabolism of chlorpropham by adult rat hepatocytes co-cultured with a liver epithelial cell line.

C. Escrieut, J. Alary, C. Pinchon, 1990, Food additives and contaminants.

Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.

N. Vaysse, C. Escrieut, D. Fourmy, 1993, European journal of biochemistry.

Cadmium-induced alterations of chlorpropham metabolism in isolated rat hepatocytes.

C. Escrieut, J. Alary, Y. Lamboeuf, 1989, Toxicology.

Role of the extracellular domains of the cholecystokinin receptor in agonist binding.

S. Silvente-Poirot, S. Wank, C. Escrieut, 1998, Molecular pharmacology.

Molecular cloning, developmental expression and pharmacological characterization of the CCKB/gastrin receptor in the calf pancreas.

H. Prats, N. Vaysse, P. Guilloteau, 1996, European journal of pharmacology.

Mapping of ligand binding sites of the cholecystokinin-B/gastrin receptor with lipo-gastrin peptides and molecular modeling.

G. Müller, H. Kessler, L. Moroder, 1997, Biopolymers.

Molecular Mechanism Underlying Partial and Full Agonism Mediated by the Human Cholecystokinin-1 Receptor*

B. Maigret, L. Pradayrol, C. Seva, 2005, Journal of Biological Chemistry.

Modeled structure of a G-protein-coupled receptor: the cholecystokinin-1 receptor.

Luis Moroder, Bernard Maigret, B. Maigret, 2005, Journal of medicinal chemistry.

Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients.

C. Dina, P. Froguel, S. Marchal-Victorion, 2002, Pharmacogenetics.

Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin

B. Maigret, E. Marco, I. Tikhonova, 2008, Regulatory Peptides.

Mechanism of Activation of a G Protein-coupled Receptor, the Human Cholecystokinin-2 Receptor*

E. Marco, I. Tikhonova, C. Escrieut, 2007, Journal of Biological Chemistry.

Partial Agonism, Neutral Antagonism, and Inverse Agonism at the Human Wild-Type and Constitutively Active Cholecystokinin-2 Receptors

Bernard Maigret, Irina G Tikhonova, B. Maigret, 2006, Molecular Pharmacology.

Evidence That Interspecies Polymorphism in the Human and Rat Cholecystokinin Receptor-2 Affects Structure of the Binding Site for the Endogenous Agonist Cholecystokinin*

Bernard Maigret, Irina G Tikhonova, B. Maigret, 2005, Journal of Biological Chemistry.

Identification of Determinants of Glucose-Dependent Insulinotropic Polypeptide Receptor That Interact with N-Terminal Biologically Active Region of the Natural Ligand

T. Yaqub, I. Tikhonova, C. Escrieut, 2010, Molecular Pharmacology.

Probing a model of a GPCR/ligand complex in an explicit membrane environment: the human cholecystokinin-1 receptor.

Christophe Chipot, Jérôme Hénin, Bernard Maigret, 2006, Biophysical journal.

Regulation of Membrane Cholecystokinin-2 Receptor by Agonists Enables Classification of Partial Agonists as Biased Agonists*

P. Cordelier, C. Escrieut, D. Fourmy, 2010, The Journal of Biological Chemistry.

Differential expression of the CCK‐A and CCK‐B/gastrin receptor genes in human cancers of the esophagus, stomach and colon

N. Vaysse, T. André, C. Escrieut, 1997, International journal of cancer.

Functional elements of the gastric inhibitory polypeptide receptor: Comparison between secretin- and rhodopsin-like G protein-coupled receptors.

L. Pardo, C. Escrieut, D. Fourmy, 2015, Biochemical pharmacology.

Spectrophotometric determination of guanazole and aminotriazole in waters from an aminotriazole production plant

J. Vandaele, C. Escrieut, J. Alary, 1985 .

Met-195 of the Cholecystokinin-A Receptor Interacts with the Sulfated Tyrosine of Cholecystokinin and Is Crucial for Receptor Transition to High Affinity State*

B. Maigret, N. Vaysse, S. Silvente-Poirot, 1998, The Journal of Biological Chemistry.

Identification of tyrosine 189 and asparagine 358 of the cholecystokinin 2 receptor in direct interaction with the crucial C-terminal amide of cholecystokinin by molecular modeling, site-directed mutagenesis, and structure/affinity studies.

Luis Moroder, Bernard Maigret, Céline Galés, 2003, Molecular pharmacology.

Determination of 2-carboxy thiazolidine-4-carboxylic acid in biological fluids by ion-exchange chromatography.

C. Escrieut, J. Alary, G. Carrera, 1989, Journal of pharmaceutical and biomedical analysis.

Linking Non-peptide Ligand Binding Mode to Activity at the Human Cholecystokinin-2 Receptor*

C. Escrieut, D. Fourmy, C. Low, 2008, Journal of Biological Chemistry.